Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|12|6|488-494

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.12, Iss.6, 2015-07, pp. : 488-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments in Cholinesterases Inhibitors for Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 14, Iss. 25, 2007-10 ,pp. : 2654-2679

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Bridging Studies in the Development of Cholinesterase Inhibitors for Alzheimer’s Disease

By Cutler N.R.   Sramek J.J.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 355-364

Adis International

Access to resources Recommend Favorite

6-Benzothiazolyl Ureas, Thioureas and Guanidines are Potent Inhibitors of ABAD/17#946;-HSD10 and Potential Drugs for Alzheimer#34;s Disease Treatment: Design, Synthesis and in vitro Evaluation

By  

Medicinal Chemistry, Vol. 13, Iss. 4, 2017-05 ,pp. : 345-358

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite